Population Pharmacokinetics and Safety of Oral Tetra-Arsenic Tetra-Sulfide Formula in Pediatric Acute Promyelocytic Leukemia

BACKGROUND: An oral tetra-arsenic tetra-sulfide (AS(4)S(4)) formula has been recommended as an outpatient post-remission treatment for Chinese adults with acute promyelocytic leukemia (APL) but limited data are available for children. In this exploratory study, we aimed to evaluate the pharmacokinet...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Drug Des Devel Ther
Glavni autori: Zhang, Li, Yang, Xin-Mei, Chen, Jing, Hu, Lei, Yang, Fan, Zhou, Yue, Zhao, Bei-Bei, Zhao, Wei, Zhu, Xiao-Fan
Format: Artigo
Jezik:Inglês
Izdano: Dove 2021
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8071704/
https://ncbi.nlm.nih.gov/pubmed/33911851
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S305244
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items